Association of eNOS Glu298Asp gene polymorphism with essential hypertension in Asian Indians

Clinica Chimica Acta

Volumn 387, Issue 1-2, 2008, Pages 80-83

  Srivastava, Kamna ^a   Narang, Rajiv ^a   Sreenivas, V ^a   Das, Sabri ^a   Das, Nibhriti ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

eNOS gene polymorphism; Essential hypertension; Glu298Asp; Malondialdehyde; Nitric oxide

Indexed keywords

ASPARTIC ACID; DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; MALONALDEHYDE; NITRIC OXIDE;

ADULT; ALLELE; ARTICLE; ASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; INDIA; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEX DIFFERENCE;

ADULT; ALLELES; ASPARTIC ACID; FEMALE; GENOTYPE; GLUTAMIC ACID; HUMANS; HYPERTENSION; INDIA; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC;

EID: 35748964459     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.09.007     Document Type: Article

References (24)

1. Bhopal R., and Weibe S.S. Cardiovascular risks and outcomes: ethnic variations in hypertensive patients. Heart 83 (2000) 495-496
2. Kashyap M.K., Yadav V., Sherawat B.S., et al. Different antioxidant status, total antioxidant power and free radicals in essential hypertension. Mol Cell Biochem 277 (2005) 89-99
3. Chern T.H., and Chiang F.T. Molecular genetic study of hypertension. Acta Cardiol Sin 20 (2004) 129-138
4. Huang P.L., Huang Z., Mashimo H., et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377 (1995) 239-242
5. Lake-Bruse K.D., Faraci F.M., Shesely E.G., Maeda N., Sigmund C.D., and Heisted D.D. Gene transfer of endothelial nitric oxide synthase (eNOS) in eNOS deficient mice. Am J Physiol 277 (1999) 770-776
6. Hingorani A.D., Liang C.F., Fatibene J., et al. A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100 (1999) 1515-1520
7. Miyamoto Y., Saito Y., Kajiyama N., et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32 (1998) 3-8
8. Tesauro M., Thomspon W.C., Rogliani P., Qi L., Chaudhary P.P., and Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs.glutamate at position 298. Proc Natl Acad Sci 97 (2000) 2832-2835
9. Rankinen T., Rice T., Perusse L., et al. NOS3 Glu298Asp genotype and blood pressure response to endurance training, the heritage family study. Hypertension 36 (2000) 885-889
10. Antoniades C., Tousoulis D., Vasiliadou C., et al. Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction. J Am Coll Cardiol 46 (2005) 1101-1109
11. Leeson C.P.M., Hingorani A.D., Mullen M.J., et al. Glu298Asp endothelial Nitric Oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res 90 (2002) 1153-1158
12. Hibi K., Ishigami T., Tamura K., et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32 (1998) 521-526
13. Lacolley P., Gautier S., Poirier O., Pannier B., Cambien F., and Benetos A. Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 16 (1998) 31-35
14. 894 polmorphism in the gene for endothelial nitic oxide synthase and blood pressure in lead-exposed workers from Korea. J Occup Environ Med 16 (2001) 581-590
15. Kato N., Sugiyama T., Morita H., et al. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 33 (1999) 933-936
16. Gupta R. Meta-analysis of prevalence of hypertension in India. Indian Heart J 49 (1997) 43-48
17. Srivastava K., Biswas U.K., Narang R., Varghese J.J., and Das N. Prevalence of eNOS Glu298Asp polymorphism in healthy volunteers from a region of Northern India. Community Genet 8 (2005) 180-183
18. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
19. Gardemann A., Lohre J., Cayci S., Katz N., Tillmanns H., and Haberbosch W. The T allele of the missense Glu298Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile. Atherosclerosis 160 (2002) 167-176
20. 298→Asp polymorphism) to the presence, extent and severity of coronary artery disease. Heart 87 (2002) 525-528
21. Berdeli A., Sekuri C., Cam S.F., et al. Asociation between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery diseases in a Turkish population. Clin Chim Acta 351 (2005) 87-94
22. Shoji M., Tsutaya S., Saito R., Takamatu H., and Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci 66 (2000) 2557-2562
23. Tsujita Y., Baba S., Yamauchi R., et al. Association analyses between genetic polymorphism of endothelial nitric oxide synthase gene and hypertension in Japanese. The Suita study. J Hypertens 19 (2001) 1941-1948
24. Stamler J., Stamler R., Riedlinger W.F., Algera G., and Roberts R.H. Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) Program, 1973-1975. JAMA 235 (1976) 2299-2306